Trial intelligence / Profile preview

Nepafenac vs Ketorolac for Pain and Healing after PRK

NCT00330798Phase 4Completed

Sponsor
Alcon Inc.
Start
Feb 2006
Primary completion
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nepafenac in postoperative pain, sponsored by Alcon Inc.. Started Feb 2006; status: completed.

02

Drugs

nepafenac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00330798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00330798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call